One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor: A Randomized Trial | Gastroenterology | JAMA | JAMA Network https://t.co/1NWIth9IVz
873 followers
3,903 followers
@PatrickKenneyMD @montypal @Robert_Uzzo @LaurenCHarshman @allaf_mo @KidneyCancerDoc @KidneyCancer @virajmaster I wonder whether Sutent effect is analogous to adjuvant gleevac for hi-risk GIST: Benefit in RFS/not OS w/1 yr, improved RFS AND OS with 3 yr htt
356 followers
Z9001の後はこうなってたのか。1 vs 3 yrs of adjuvant imatinib for operable GIST: a randomized trial. - PubMed - NCBI http://t.co/KFMLmlSIkP
1,140 followers
One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor. http://t.co/ikNS907X